Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling

Ke Lin(Sir Run Run Shaw Hospital), Peiren Shan(Wenzhou University)
Acta Pharmacologica Sinica
February 25, 2022
Cited by 65


Related Papers